BioSpace News Archive

MedyMatch Technology announced today an exciting new phase in its growth with the launch of its new corporate identity as MaxQ-AI.

Market research firm Technavio has announced the release of their latest report on the global hospital stretchers market.

Health Canada to report on the outcome of its public consultation on the Regulation of Cannabis

Feinstein Institute for Medical Research scientists announced an experimental, rapid and non-invasive way to diagnose endometriosis, which may lead to earlier and more effective treatments for this disorder that affects approximately 176 million women globally.

In cooperation with the Taylor Farms recall of diced yellow onions that may be contaminated with Salmonella, 12 Haggen stores are voluntarily recalling deli products that contain raw Taylor Farms brand diced yellow onions.

Media worldwide are invited to attend a press event announcing the results of the 2018 State of Smoking Survey, a study commissioned by the Foundation for a Smoke-Free World that aims to better understand why people smoke.

The Society Of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to Karim Valji, M.D., FSIR; John A. Kaufman, M.D., M.S., FSIR; and Renate L. Soulen, M.D., FSIR, during its Annual Scientific Meeting in Los Angeles.

The Society Of Interventional Radiology Foundation presented this year’s Frederick S. Keller, M.D., Philanthropy Award posthumously to Constantin Cope, M.D., FSIR, at the foundation’s annual Gala on March 18, held in conjunction with the Society of Interventional Radiology’s (SIR) Annual Scientific Meeting in Los Angeles.

Harnessing the innovative spirit that launched interventional radiology is key to ensuring the specialty’s continued evolution and expansion, said Timothy P. Murphy, M.D., FSIR, who delivered the Society Of Interventional Radiology (SIR) 2018 Dr. Charles T. Dotter Lecture on March 18 during SIR’s Annual Scientific Meeting in Los Angeles.

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the Centers for Medicare & Medicaid Services (CMS) issued a final National Coverage Determination (NCD) for patients who receive next generation sequencing (NGS) testing with an assay that meets the coverage criteria.